Latest Insider Transactions at Viemed Healthcare, Inc. (VMD)
This section provides a real-time view of insider transactions for Viemed Healthcare, Inc. (VMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VIEMED HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VIEMED HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 18
2024
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,490
-7.75%
|
$66,430
$7.62 P/Share
|
Jan 17
2024
|
Jeremy Trahan General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,742
-20.08%
|
$12,194
$7.39 P/Share
|
Jan 17
2024
|
Jeremy Trahan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,106
+27.81%
|
-
|
Jan 17
2024
|
Jeremy Trahan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,221
-24.37%
|
$8,547
$7.39 P/Share
|
Jan 17
2024
|
Casey Hoyt Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,357
-7.39%
|
$93,499
$7.39 P/Share
|
Jan 17
2024
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,086
+12.19%
|
-
|
Jan 17
2024
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,017
-6.65%
|
$70,119
$7.39 P/Share
|
Jan 17
2024
|
Trae Fitzgerald Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,420
-5.15%
|
$23,940
$7.39 P/Share
|
Jan 17
2024
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,989
+8.26%
|
-
|
Jan 17
2024
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,398
-4.05%
|
$16,786
$7.39 P/Share
|
Jan 17
2024
|
Jerome Cambre Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
3,040
-4.09%
|
$21,280
$7.39 P/Share
|
Jan 17
2024
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
10,656
+6.66%
|
-
|
Jan 17
2024
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,131
-3.13%
|
$14,917
$7.39 P/Share
|
Jan 17
2024
|
William Todd Zehnder Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,639
-4.38%
|
$67,473
$7.39 P/Share
|
Jan 17
2024
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,675
+7.09%
|
-
|
Jan 17
2024
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,735
-3.37%
|
$47,145
$7.39 P/Share
|
Jan 17
2024
|
Michael Moore President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,369
-7.66%
|
$65,583
$7.39 P/Share
|
Jan 17
2024
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
33,675
+12.12%
|
-
|
Jan 17
2024
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,735
-6.59%
|
$47,145
$7.39 P/Share
|
Aug 22
2023
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+14.4%
|
-
|
Aug 22
2023
|
William Frazier Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,135
-5.97%
|
$33,080
$8.1 P/Share
|
Aug 22
2023
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+16.42%
|
-
|
Aug 22
2023
|
Bruce D Greenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+17.1%
|
-
|
Aug 22
2023
|
Sabrina Heltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+26.24%
|
-
|
Aug 22
2023
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+10.48%
|
-
|
Aug 22
2023
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+14.39%
|
-
|
Aug 14
2023
|
Casey Hoyt Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
2,010,943
+50.0%
|
-
|
Aug 14
2023
|
Casey Hoyt Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,010,943
-93.46%
|
-
|
Aug 14
2023
|
Michael Moore President |
BUY
Bona fide gift
|
Indirect |
1,722,614
+50.0%
|
-
|
Aug 14
2023
|
Michael Moore President |
SELL
Bona fide gift
|
Direct |
1,722,614
-94.75%
|
-
|
Jun 14
2023
|
Timothy Smokoff Director |
SELL
Open market or private sale
|
Direct |
10,361
-13.34%
|
$134,693
$13.51 P/Share
|
Jun 14
2023
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,361
+11.77%
|
$20,722
$2.27 P/Share
|
May 09
2023
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,381
-0.18%
|
$63,810
$10.49 P/Share
|
May 09
2023
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
6,381
+0.17%
|
-
|
May 09
2023
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,295
-1.61%
|
$62,950
$10.49 P/Share
|
May 09
2023
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,295
+1.58%
|
-
|
May 09
2023
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,953
-1.46%
|
$19,530
$10.49 P/Share
|
May 09
2023
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
1,953
+1.44%
|
-
|
May 09
2023
|
Ewell Patrick Eagan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100
-4.24%
|
$1,000
$10.49 P/Share
|
May 09
2023
|
Ewell Patrick Eagan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+4.06%
|
-
|
May 09
2023
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,244
-1.94%
|
$22,440
$10.49 P/Share
|
May 09
2023
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,244
+1.9%
|
-
|
May 09
2023
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,455
-0.22%
|
$94,550
$10.49 P/Share
|
May 09
2023
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,455
+0.22%
|
-
|
Mar 17
2023
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
12,087
-10.55%
|
$157,131
$13.43 P/Share
|
Mar 17
2023
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,087
+9.54%
|
$24,174
$2.27 P/Share
|
Jan 18
2023
|
Ewell Patrick Eagan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,271
+50.0%
|
-
|
Jan 18
2023
|
Ewell Patrick Eagan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,757
-100.0%
|
$12,299
$7.77 P/Share
|
Jan 18
2023
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,783
+7.03%
|
-
|
Jan 18
2023
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,378
-5.96%
|
$23,646
$7.77 P/Share
|